Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: A comparison between adults and children

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Han, Seung Beom ^a   Bae, E Young ^a   Lee, Jae Wook ^a   Lee, Dong Gun ^a   Chung, Nack Gyun ^a   Jeong, Dae Chul ^a   Cho, Bin ^a   Kang, Jin Han ^a   Kim, Hack Ki ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Bacteremia; Fever; Neutropenia; Viridans streptococci

Indexed keywords

CEFEPIME; CEFOTAXIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LINEZOLID; PENICILLIN DERIVATIVE; VANCOMYCIN;

ABDOMINAL PAIN; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ADVERSE OUTCOME; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; DISEASE SEVERITY; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; ORAL MUCOSITIS; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RETROSPECTIVE STUDY; STREPTOCOCCUS VIRIDANS INFECTION;

ADULT; AGE FACTORS; ANTI-BACTERIAL AGENTS; BACTEREMIA; CEPHALOSPORINS; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; STREPTOCOCCAL INFECTIONS; VIRIDANS STREPTOCOCCI;

EID: 84879044994     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-273     Document Type: Article

References (34)

1. Castagnola E, Fontana V, Caviglia I, Caruso S, Faraci M, Fioredda F, Garrè ML, Moroni C, Conte M, Losurdo G, Scuderi F, Bandettini R, Tomà P, Viscoli C, Haupt R. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis 2007, 45(10):1296-1304. 10.1086/522533, 17968824.
2. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 2011, 52(4):e56-93. 10.1093/cid/cir073, 21258094.
3. Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur AH. Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol 2009, 31(9):623-629. 10.1097/MPH.0b013e3181b1edc6, 2743072, 19644403.
4. Ko EY, Kang HJ, Kwon HJ, Choi UY, Lee JW, Lee DG, Park YJ, Chung NG, Cho B, Kim HK, Kang JH. Clinical investigation of bacteremia in children with hemato-oncologic diseases. Infect Chemother 2011, 43(2):191-197.
5. Marron A, Carratala J, Gonzalez-Barca E, Fernandez-Sevilla A, Alcaide F, Gudiol F. Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer. Clin Infect Dis 2000, 31(5):1126-1130. 10.1086/317460, 11073739.
6. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis 1999, 29(3):490-494. 10.1086/598620, 10530434.
7. Kwon JC, Kim SH, Choi JK, Cho SY, Park YJ, Park SH, Choi SM, Lee DG, Choi JH, Yoo JH. Epidemiology and clinical features of bloodstream infections in hematology wards: one year experience at the Catholic Blood and Marrow Transplantation Center. Infect Chemother 2013, 45(1):51-61.
8. Gassas A, Grant R, Richardson S, Dupuis LL, Doyle J, Allen U, Abla O, Sung L. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients. J Clin Oncol 2004, 22(7):1222-1227. 10.1200/JCO.2004.09.108, 15051769.
9. Husain E, Whitehead S, Castell A, Thomas EE, Speert DP. Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility. Pediatr Infect Dis J 2005, 24(6):563-566. 10.1097/01.inf.0000164708.21464.03, 15933573.
10. Spanik S, Trupl J, Kunova A, Botek R, Sorkovska D, Grey E, Studena M, Lacka J, Oravcova E, Krchnakova A, Rusnakova V, Svec J, Krupova I, Grausova S, Stopkova K, Koren P, Krcmery V. Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis. Scand J Infect Dis 1997, 29(3):245-249. 10.3109/00365549709019036, 9255883.
11. Martino R, Subirá M, Manteiga R, Badell I, Argilés B, Sureda A, Brunet S. Viridans streptococcal bacteremia and viridans streptococcal shock syndrome in neutropenic patients: comparison between children and adults receiving chemotherapy or undergoing bone marrow transplantation. Clin Infect Dis 1995, 20(2):476-477. 10.1093/clinids/20.2.476, 7742466.
12. Lee DG, Kim SH, Kim SY, Kim CJ, Park WB, Song YG, Choi JH. Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med 2011, 26(2):220-252. 10.3904/kjim.2011.26.2.220, 3110859, 21716917.
13. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI document M100-S20 2010, Wayne, PA: Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute.
14. Maier RV. Approach to the patient with shock. Harrison's principles of internal medicine. 18th ed 2011, 2215-2222. Jurong, Singapore: McGraw-Hill, Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J.
15. Turner DA, Cheifetz IM. Shock. Nelson textbook of pediatrics. 19th ed 2011, 305-314. Philadelphia, PA: Saunders, Kliegman RM, Stanton BF, St. Geme JW, Schor NF, Behrman RE.
16. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007, 369(9572):1553-1564. 10.1016/S0140-6736(07)60604-7, 17482987.
17. Ortega M, Rovira M, Almela M, Marco F, de la Bellacasa JP, Martínez JA, Carreras E, Mensa J. Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000. Ann Hematol 2005, 84(1):40-46. 10.1007/s00277-004-0909-0, 15480665.
18. Reilly AF, Lange BJ. Infections with viridans group streptococci in children with cancer. Pediatr Blood Cancer 2007, 49(6):774-780. 10.1002/pbc.21250, 17588233.
19. Ruescher TJ, Sodeifi A, Scrivani SJ, Kaban LB, Sonis ST. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 1998, 82(11):2275-2281. 10.1002/(SICI)1097-0142(19980601)82:11<2275::AID-CNCR25>3.0.CO;2-Q, 9610710.
20. Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 2002, 34(11):1524-1529. 10.1086/340402, 12015700.
21. Bruckner L, Gigliotti F. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance. Semin Pediatr Infect Dis 2006, 17(3):153-160. 10.1053/j.spid.2006.06.008, 16934710.
22. Westling K, Julander I, Ljungman P, Heimdahl A, Thalme A, Nord CE. Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease. Clin Microbiol Infect 2004, 10(10):899-903. 10.1111/j.1469-0691.2004.00975.x, 15373884.
23. Ghaffar F, Friedland IR, Katz K, Muniz LS, Smith JL, Davis P, Reynolds J, McCracken GH. Increased carriage of resistant non-pneumococcal alpha-hemolytic streptococci after antibiotic therapy. J Pediatr 1999, 135(5):618-623. 10.1016/S0022-3476(99)70061-2, 10547251.
24. Hooper DC, Strahilevitz J. Quinolones. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 7th ed 2009, 487-510. Philadelphia, PA: Churchill Livingstone, Mandell GL, Bennett J, Dolin R.
25. van de Wetering MD, de Witte MA, Kremer LC, Offringa M, Scholten RJ, Caron HN. Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials. Eur J Cancer 2005, 41(10):1372-1382. 10.1016/j.ejca.2005.03.006, 15913983.
26. Rungoe C, Malchau EL, Larsen LN, Schroeder H. Infections during induction therapy for children with acute lymphoblastic leukemia. The role of sulfamethoxazole-trimethoprim (SMX-TMP) prophylaxis. Pediatr Blood Cancer 2010, 55(2):304-308. 10.1002/pbc.22423, 20583218.
27. Gafter-Gvili A, Fraser A, Paul M, Leibovici L. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 2005, 142(12 Pt 1):979-995.
28. Kern W, Linzmeier K, Kurrle E. Antimicrobial susceptibility of viridans group streptococci isolated from patients with acute leukemia receiving ofloxacin for antibacterial prophylaxis. Infection 1989, 17(6):396-397. 10.1007/BF01645556, 2613331.
29. Prabhu RM, Piper KE, Litzow MR, Steckelberg JM, Patel R. Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis. Eur J Clin Microbiol Infect Dis 2005, 24(12):832-838. 10.1007/s10096-005-0037-3, 16331335.
30. Dowson CG, Hutchison A, Woodford N, Johnson AP, George RC, Spratt BG. Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae. Proc Natl Acad Sci USA 1990, 87(15):5858-5862. 10.1073/pnas.87.15.5858, 54428, 2377622.
31. Ergin A, Eser T, Hasçelik G. Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases. New Microbiol 2011, 34(2):187-193.
32. Soeters HM, von Gottberg A, Cohen C, Quan V, Klugman KP. Trimethoprim-sulfamethoxazole prophylaxis and antibiotic nonsusceptibility in invasive pneumococcal disease. Antimicrob Agents Chemother 2012, 56(3):1602-1605. 10.1128/AAC.05813-11, 3294938, 22232291.
33. Kim SH, Song JH, Chung DR, Thamlikitkul V, Yang Y, Wang H, Lu M, So TM, Hsueh PR, Yasin RM, Carlos CC, Pham HV, Lalitha MK, Shimono N, Perera J, Shibi AM, Baek JY, Kang CI, Ko KS, Peck KR, ANSORP Study Group Changing trends in antimicrobial resistance and serotype of Streptococcus pneumoniae isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Antimicrob Agents Chemother 2012, 56(3):1418-1426. 10.1128/AAC.05658-11, 3294909, 22232285, ANSORP Study Group.
34. Kern WV, Steib-Bauert M, de With K, Reuter S, Bertz H, Frank U, von Baum H. Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999-2002. J Antimicrob Chemother 2005, 55(1):57-60.